ライフサイエンスコーパス: spirometry

1 COPD and 26 with chronic bronchitis (normal spirometry).

2 tionnaires and lung function was measured by spirometry.

3 ed with hospital-based and weekly home-based spirometry.

4 previously identified in analyses of COPD or spirometry.

5 F%p) from baseline to week 52, measured with spirometry.

6 determination of carbon monoxide uptake and spirometry.

7 olume loops, and at 10 and 16 years by using spirometry.

8 performance and interpretation of workplace spirometry.

9 chest radiography, only 2296 (33%) also had spirometry.

10 adults with cystic fibrosis who have normal spirometry.

11 Diagnosis of COPD was confirmed by spirometry.

12 lmonary disease and/or airflow limitation on spirometry.

13 180 participants who also underwent CTs and spirometry.

14 multaneously acquiring metabolic values with spirometry.

15 times between 1984 and 2003 with concurrent spirometry.

16 y of symptoms, and lung function measured by spirometry.

17 All subjects had normal spirometry.

18 ts and three on lung function as measured by spirometry.

19 questionnaire on respiratory symptoms and by spirometry.

20 c obstructive pulmonary disease (COPD) using spirometry.

21 Do not screen adults for COPD using spirometry.

22 V1 less than 60% predicted, as documented by spirometry.

23 to assess a clinically meaningful change in spirometry.

24 iratory volume in 1 s (FEV1) was measured by spirometry.

25 ation of reversible airway obstruction using spirometry.

26 nt prebronchodilator and post-bronchodilator spirometry.

27 Study, we examined 7,225 with COPD based on spirometry.

28 No safety concerns were associated with spirometry.

29 rs and instruction on how to self-administer spirometry.

30 ymptoms were invited for post-bronchodilator spirometry.

31 At recruitment we measured anthropometrics, spirometry, 6-minute walk distance, dyspnea, BODE index,

32 uality-of-life assessments, polysomnography, spirometry, 6-minute-walk distance, dropouts, compliance

33 Repeated spirometry, 6MWD, and peripheral blood T-cell cytokine r

34 The MESA Lung Study measured spirometry according to American Thoracic Society guidel

35 types remained normal for GLI-defined normal spirometry across GOLD spirometric categories.

36 acity (FVC) of less than 0.70 as assessed by spirometry after bronchodilator use.

37 time between 09/11/2001 and a worker's first spirometry afterwards was 3 mo; 90% were assessed within

38 etermination has been limited by reliance on spirometry alone to assess disease severity in predomina

39 e of onset and duration of symptoms, and (i) spirometry and (ii) small airway involvement measured by

40 Spirometry and a respiratory questionnaire including occ

41 Neonatal spirometry and bronchial responsiveness to methacholine

42 12, and 18 months (respiratory symptoms) and spirometry and CO (ppm) in exhaled breath measurements.

43 s (49% with COPD) aged 40-85 years performed spirometry and CT examination.

44 ficients (ICCs), and their associations with spirometry and CT measurements of 15th percentile attenu

45 Diagnosis of COPD was based on spirometry and defined according to the GOLD guidelines.

46 reference sources are updated with data for spirometry and diffusing capacity published since prior

47 Subjects performed spirometry and had fraction of exhaled nitric oxide valu

48 Spirometry and health status (as assessed by St.

49 sitive early RA (<1-year duration) underwent spirometry and high-resolution computed tomography (HRCT

50 etic variance in phenotypes of COPD, such as spirometry and imaging variables.

51 vestigated small airway function assessed by spirometry and impulse oscillometry, as well as Borg dys

52 Both groups underwent spirometry and induced sputum at baseline and at 1, 3, a

53 hypothesis, there was no correlation between spirometry and LCI in PCD and no correlation between HRC

54 CF and 33 patients with PCD, all of whom had spirometry and LCI, of which a subset of 21 of each had

55 concentrations 1, 2, 3, 5, and 7 days before spirometry and lung function.

56 rican Thoracic Society guidelines using both spirometry and lung volumes.

57 We studied 3851 subjects who underwent spirometry and methacholine challenge tests both at base

58 s without respiratory diseases who underwent spirometry and MostGraph-01 from January to October 2014

59 ing history, >/=10 pack-years), we evaluated spirometry and multiple phenotypes, including dyspnea se

60 Lung volumes were measured by spirometry and plethysmography in 109 healthy subjects a

61 roved HIPAA-compliant protocol and underwent spirometry and plethysmography, completed the St George'

62 We measured lung function using spirometry and plethysmography.

63 At each visit, participants completed spirometry and questionnaires assessing respiratory symp

64 unction and atopic status were determined by spirometry and skin prick testing.

65 and children were invited for measurement of spirometry and skin-prick testing.

66 ection of pulmonary exacerbations using home spirometry and symptom monitoring would result in slower

67 arly intervention arm subjects measured home spirometry and symptoms electronically twice per week.

68 Screening spirometry and tests of diffusing capacity might be bene

69 of bronchodilator response measured by using spirometry and the global imaging metric percentage vent

70 healthy patients who did not smoke underwent spirometry and two separate 1.5-T MR imaging examination

71 tion (n=2042) underwent echocardiography and spirometry and was followed up for a median of 9 years.

72 val) adults with persistent asthma underwent spirometry and were administered the A-IQOLS, other asth

73 participate, of whom 588 provided acceptable spirometry and were analysed.

74 e chest, resting pulmonary function studies (spirometry and/or plethysmography), and a cardiology eva

75 measured lung function (plethysmography and spirometry) and airway hyper-reactivity (AHR; methacholi

76 ymptoms, rescue medication use, and baseline spirometry) and morbidity (school absences and unschedul

77 lth-related quality-of-life assessments, the spirometry, and 6-minute-walk distance results improved

78 oup and control subjects had symptom scores, spirometry, and bronchoalveolar lavage before and after

79 inistered to participants, chest tomography, spirometry, and examination of induced sputum.

80 sis were recruited and lung clearance index, spirometry, and health-related quality of life measures

81 connective tissue disease (CTD) serologies, spirometry, and high-resolution computed tomography ches

82 llowed with repeated questionnaires, dynamic spirometry, and IgE measurements until 8 years of age.

83 We show for the first time that HRCT, spirometry, and LCI have different relationships in diff

84 10 patients with COPD underwent MR imaging, spirometry, and plethysmography.

85 ratory Health Survey provided serum samples, spirometry, and questionnaire data about respiratory and

86 standardized questionnaires, guideline-based spirometry, and segmental airway dimensions and percenta

87 with home peak flow and symptom monitoring, spirometry, and serial bronchial challenge tests, and th

88 inical questionnaire, skin prick test (SPT), spirometry, and serum total and specific IgE (sIgE) were

89 g Initiative (GLI-2012) reference values for spirometry are appropriate for children in sub-Saharan A

90 Important aspects of workplace spirometry are discussed and recommendations are provide

91 RATIONALE: Accurate reference values for spirometry are important because the results are used fo

92 Outcomes other than spirometry are required to assess nonbronchodilator ther

93 Computed tomography (CT) and spirometry are the mainstays of clinical pulmonary asses

94 Insufficient evidence supports preoperative spirometry as a tool to stratify risk.

95 Most studies have used spirometry as the primary assessment of airway obstructi

96 ealed from the researchers who performed the spirometry assessments.

97 a on clinical history, physical examination, spirometry, asthma control test, and doctor's diagnosis

98 children, recording respiratory symptoms and spirometry at 12 and 18 years.

99 a prospective birth cohort study, performed spirometry at 8 and 16 years and IOS at 16 years of age.

100 Stockholm, Epidemiological Survey) performed spirometry at age 16 years.

101 e in the baseline cohort, 13,756 (88.5%) had spirometry at the Year 3 visit.

102 ake were randomized, and 345 (89%) completed spirometry at week 24.

103 Standard spirometry, atopy traits, blood eosinophilia, and urinar

104 We subdivided participants with normal spirometry based on respiratory-related impairment (6-mi

105 ad no specific sex association, intermediate spirometry, BDR, BHR, more significant BTS step therapy

106 had the following assessments: Feno levels, spirometry, blood samples analyzed for hemoglobin, white

107 estimating equations adjusting for childhood spirometry, body mass index, age, and sex.

108 patients with asthma were characterized with spirometry, body plethysmography, impulse oscillometry,

109 e-matched healthy control subjects underwent spirometry, body plethysmography, multiple-breath inert

110 Data on spirometry, bronchial responsiveness, respiratory sympto

111 We also measured spirometry, bronchodilator reversibility, and FeNO at fo

112 ma had positive results for all three tests (spirometry, bronchodilator reversibility, and FeNO).

113 COPD can be diagnosed early using spirometry, but spirometry use is only recommended in sy

114 ndardized procedures for diagnostic testing, spirometry, chest computed tomography, respiratory cultu

115 ere then classified according to features on spirometry, chest imaging, and histopathological specime

116 monoxide was tested and volunteers underwent spirometry, chest x-ray study, and a bronchoalveolar lav

117 ym I COUGH, the program emphasizes incentive spirometry, coughing and deep breathing, oral care (brus

118 Spirometry data were analyzed from 1,082 schoolchildren

119 Full montage home sleep testing and spirometry data were analyzed on 6,173 participants of t

120 ographics, clinical, and post-bronchodilator spirometry data were collected at an in-person study vis

121 Standardized spirometry data were collected at the baseline examinati

122 Yearly best spirometry data, collected during 8.6 +/- 1 year per pat

123 pe was related to 1989, 1995, 2001, and 2014 spirometry data.

124 ents were more likely to have rapid-onset of spirometry decline (P = 0.05) and lower FEV1% predicted

125 ansion interventions (for example, incentive spirometry, deep breathing exercises, and continuous pos

126 Although both LCI and spirometry discriminated health from disease, only the L

127 ts from the NETT performed prebronchodilator spirometry during two baseline sessions.

128 king history, 44.3 pack-years), we evaluated spirometry, dyspnea (modified Medical Research Council g

129 After surgery, early mobilization, incentive spirometry, early nasogastric tube removal, alvimopan us

130 ine recipient, donor, and surgical data; all spirometry evaluations; acute cellular rejection (ACR) e

131 GLI-defined normal spirometry, even when classified as respiratory impairme

132 ratory flow (PEF), and when stable underwent spirometry every 3 months, and completed the St. George'

133 Demographics, spirometry, exercise tolerance, symptom questionnaires,

134 performed exhaled nitric oxide measurement, spirometry, exhaled breath condensate (EBC) collection.

135 nt symptom assessment (Asthma Control Test), spirometry, exhaled nitric oxide and induced sputum eval

136 Children also underwent spirometry, exhaled nitric oxide, allergy skin testing t

137 mographics, dust exposure history, symptoms, spirometry, exhaled nitric oxide, and blood (for immunog

138 is, angioedema, or acute urticaria underwent spirometry, exhaled nitric oxide, questionnaires, and se

139 Spirometry, FeNO, ACQ and AQLQ were significantly better

140 Children with CF underwent spirometry (FEV).

141 XIII (FXIII), NO in exhaled breath (FENO ), spirometry (FEV1 ) and eosinophil count (EOS) in 36 pati

142 and Asthma Symptom-Free Days questionnaire), spirometry (FEV1), rescue medication use, asthma deterio

143 preserved pulmonary function as assessed by spirometry (FEV1:FVC >/=0.70 and an FVC above the lower

144 Among 630 children who completed spirometry, FEV1:FVC was less than 70% in ten (2%) child

145 ent approaches to healthcare delivery (e.g., spirometry for diagnosis and treatment, integrated healt

146 Lower airflow values are present by spirometry for prepubertal boys than for age-matched gir

147 predicting airflow obstruction; the value of spirometry for screening or diagnosis of COPD; and COPD

148 Education and provision of incentive spirometry for unmonitored patient use does not result i

149 ren and reference data; 2) relate BC to lung spirometry [forced expired volume in 1 s (FEV)]; and 3)

150 Results of spirometry, fractional exhaled nitric oxide (Feno), mann

151 g 5,100 participants with GLI-defined normal spirometry, GOLD identified respiratory impairment in 1,

152 st that among adults with GLI-defined normal spirometry, GOLD may misclassify normal phenotypes as ha

153 Relative to normal spirometry, graded associations with respiratory-related

154 Although spirometry has limited sensitivity for detecting small-a

155 Spirometry has not been shown to independently increase

156 low BDR and BHR, impaired but non-obstructed spirometry, high symptom frequency and highest smoking p

157 , increased BDR and BHR, moderately impaired spirometry, high symptom severity and higher BTS step th

158 We performed spirometry in 1371 of the children (83% of those eligibl

159 = 8,583) and studied with prebronchodilator spirometry in 1968 was retraced (n = 7,312) and resurvey

160 GLI established normal spirometry in 5,100 patients (50.3%), mild COPD in 669 (

161 more sensitive measure of lung function than spirometry in cystic fibrosis (CF) and correlates well w

162 a vasoocclusive crisis, and use of incentive spirometry in patients hospitalized for a vasoocclusive

163 Measurement of daily home spirometry in patients with IPF is highly clinically inf

164 correlation between HRCT features and LCI or spirometry in PCD.

165 uction; however, the test characteristics of spirometry in the diagnosis of asthma are not well estab

166 ever, the evidence for the role of incentive spirometry in the prevention of postoperative atelectasi

167 ysiologic characteristic of COPD assessed by spirometry, in population-based cohorts examining all pa

168 Overall, the phenotype of GLI-defined normal spirometry included normal adjusted mean values for dysp

169 om subsample of 858 children was invited for spirometry, including bronchodilator tests and exhaled n

170 tween exposure in different time windows and spirometry indexes were analyzed by linear regression an

171 The yearly decline in spirometry indices was defined in relation to the preced

172 wi, using American Thoracic Society standard spirometry, internationally validated respiratory sympto

173 uding mailed screening questionnaires before spirometry is a cost-effective way to identify undiagnos

174 ma symptom control are poorly understood and spirometry is a poor predictor of symptomatic response.

175 Spirometry is effort dependent and only provides a singl

176 Screening for COPD using spirometry is likely to identify a predominance of patie

177 Today, GOLD recommends that spirometry is required for the clinical diagnosis of COP

178 Spirometry is routinely used as a clinical marker for as

179 physema on CT among patients without COPD on spirometry is warranted.

180 alpha1 antitrypsin deficiency emphysema than spirometry is, so we aimed to assess the efficacy of aug

181 Postoperative incentive spirometry (IS) is a ubiquitous practice; however, littl

182 showed no specific atopy association, normal spirometry, low BDR, BHR and symptom severity.

183 -lung-function had male predominance, normal spirometry, low bronchodilator reversibility (BDR), inte

184 reporting format in test-specific units for spirometry, lung volumes, and diffusing capacity that ca

185 ite the lack of between-group differences in spirometry, lung volumes, and left ventricular ejection

186 Spirometry, lung volumes, exhaled nitric oxide levels, a

187 s response to treatment because conventional spirometry mainly reflects large airway function.

188 eathing exercises, with or without incentive spirometry, may help counteract postoperative decreased

189 nalysed in all patients with a post-baseline spirometry measurement.

190 ch treatment group had a valid post-baseline spirometry measurement.

191 king part in the UK Biobank who had provided spirometry measurements and information on smoking.

192 had provided acceptable post-bronchodilator spirometry measurements and information on use of solid

193 ectories among participants with two or more spirometry measurements between ages 11 and 32 years.

194 ort study examining 61,650 participants with spirometry measurements from the Copenhagen City Heart S

195 significant early improvements in symptoms, spirometry measurements, and systemic inflammation of ba

196 xamined the association with current asthma, spirometry measures, and related atopic traits.

197 Spirometry measures: forced expiratory volume in 1 secon

198 ening, the following tests were carried out: spirometry, methacholine and mannitol challenge, exhaled

199 sthma and healthy control subjects underwent spirometry, methacholine challenge, and bronchoscopy, an

200 Spirometry, methacholine responsiveness, deep-breath-ind

201 questionnaire, pre- and post-bronchodilator spirometry (n = 1,389), skin prick testing, lung volumes

202 For those with normal baseline spirometry (n = 12,039), we found an excess of lung canc

203 um of smokers with lone emphysema and normal spirometry (n = 13, p < 0.01) and smokers with establish

204 bset of offspring by using blood samples and spirometry (n = 410 [45%]) and a questionnaire (n = 641

205 The 5-year outcome data were available for spirometry (n = 697), cough (n = 722), and dyspnea (n =

206 In a subset of patients with available spirometry (n=2540), higher RV ejection fraction and mas

207 They had a high rate of spirometry nonadherence (62%; not measured in heart reci

208 Spirometry, occupational endotoxin exposure, and smoking

209 ur applications and respiratory symptoms and spirometry of children living in an agricultural communi

210 for 347 children at 7 y of age and measured spirometry on a subset of 279.

211 , and performed pre- and post-bronchodilator spirometry on eligible participants.

212 f CT-assessed emphysema, but not by means of spirometry or Dlco values, is directly associated with s

213 CT (at full inspiration and expiration), and spirometry or plethysmography were performed during a 2-

214 of asthma severity, treatment requirements, spirometry, or atopy/inflammation.

215 Spirometry outcomes were compared with those of African

216 For 1,529 children with spirometry, overall geographic information system (GIS)-

217 Safety indicators included spirometry, oxygen saturation, heart rate, and symptoms.

218 We investigated the correlation between spirometry parameters and respiratory impedance, and ass

219 Five players with abnormal resting spirometry performed a bronchodilator test.

220 Spirometry performed in the work setting should be part

221 Domiciliary spirometry permits more frequent measurement of FVC than

222 onic obstructive pulmonary disease underwent spirometry, plethysmography, diffusing capacity of carbo

223 Tests included spirometry, plethysmography, sputum cell count, exhaled

224 FEV1, measured using spirometry, provides a straightforward, widely available

225 Multiethnic rather than race/ethnic-specific spirometry reference equations are applicable for the US

226 To develop spirometry reference equations for adult Hispanic/Latino

227 Current guidelines recommend separate spirometry reference equations for whites, African Ameri

228 linical practice, use of background-specific spirometry reference equations may provide more appropri

229 e the high burden of respiratory disease, no spirometry reference values for African children are ava

230 unteers (age range, 25-75 years) with normal spirometry results and no history of smoking or risk fac

231 rt that screening and supplying smokers with spirometry results improves smoking cessation rates.

232 ificant improvements in IOS outcomes but not spirometry results occurred after chronic dosing with fo

233 Lung function was evaluated by a spirometry reversibility test.

234 retired FDNY rescue workers on the basis of spirometry routinely performed at intervals of 12 to 18

235 l activity in subjects detected with COPD by spirometry screening.

236 thma diagnosis and symptoms, peak flow (PF), spirometry, serum IgE levels and white blood cell differ

237 Current spirometry should be compared with previous tests.

238 ON 1: ACP, ACCP, ATS, and ERS recommend that spirometry should be obtained to diagnose airflow obstru

239 respiratory symptoms, particularly dyspnea, spirometry should be performed to diagnose airflow obstr

240 Spirometry should not be used to screen for airflow obst

241 Spirometry should not be used to screen for airflow obst

242 Home spirometry showed excellent correlation with hospital-ob

243 uality of Life (EQ-5D) health questionnaire, spirometry, skin prick test (SPT), exhaled nitric oxide

244 Clinical-demographic questionnaire, spirometry, skin prick test and specific IgE were evalua

245 A clinical-demographic questionnaire, spirometry, skin prick test, and specific IgE to aeroall

246 life, and sputum expectoration and performed spirometry, sputum induction, cough reflex sensitivity t

247 At a single stable visit, subjects underwent spirometry; sputum fungal culture and a sputum cell diff

248 NO2 and after adjusting for race and season (spirometry standardized by age, height, and sex), NO2 le

249 sues that previous American Thoracic Society spirometry statements did not adequately address with re

250 dence related to the following: training for spirometry technicians; testing posture; appropriate ref

251 relation between the results from a standard spirometry test, forced expiratory volume in one-second

252 PSTF did not consider the financial costs of spirometry testing or COPD therapies.

253 h airflow limitation (70.6%) had no previous spirometry testing or diagnosed pulmonary disease.

254 sites (n=9425) completed postbronchodilator spirometry testing plus questionnaires about respiratory

255 Spirometry testing was completed and the pre-bronchodila

256 Spirometry testing was conducted at year 0 (1985-1986) a

257 ning and feedback can improve the quality of spirometry testing.

258 cts of the performance and interpretation of spirometry that are particularly important in the workpl

259 ngs challenge the proposed cutoff values for spirometry, the order in which the lung function tests a

260 Hundreds of patients would need to undergo spirometry to defer a single exacerbation.

261 Insufficient evidence supports using spirometry to guide therapy.

262 BEC donors completed spirometry to measure lung function.

263 ed validated questionnaires and administered spirometry to participants.

264 We also used spirometry to test BHR to acetylcholine (PC20Ach).

265 ould not recommend the addition of incentive spirometry to the current standard of care in this resou

266 After baseline prebronchodilator spirometry, to identify the presence of airflow limitati

267 can be diagnosed early using spirometry, but spirometry use is only recommended in symptomatic smoker

268 insic skin Aging) and airflow obstruction by spirometry, using the ratio of forced expiratory volume

269 Spirometry was also conducted on a subset.

270 in clinical care and interventional trials; spirometry was also conducted.

271 More severely impaired baseline spirometry was associated with a lower likelihood of imp

272 CO in exhaled breath at the same time as spirometry was associated with lower lung function [aver

273 Spirometry was completed in 403 (98%) neonates and again

274 ion, expressed as the FEV1 slope in mL/year; spirometry was done annually during follow-up for up to

275 Spirometry was measured following American Thoracic Soci

276 bstruction assessed from post-bronchodilator spirometry was not associated with use of solid fuels fo

277 Spirometry was performed according to American Thoracic

278 At the end of each study week, spirometry was performed by trained physicians, and the

279 Spirometry was performed during clinic visits at ages 3,

280 Prebronchodilator spirometry was performed for a cohort of 7-year-old Tasm

281 Spirometry was performed in 1989-1990 and 4, 7, and 16 y

282 Spirometry was performed in 2,082 patients (93%) whose m

283 At each visit, spirometry was performed repeatedly over a period of 2 h

284 Spirometry was performed using standardized methods with

285 Each day, spirometry was performed, disease severity was determine

286 Daily spirometry was recorded by 50 subjects for a median peri

287 Clinical assessment and hospital-based spirometry was undertaken at 6 and 12 months, and outcom

288 s and participants unable to be tested using spirometry were excluded.

289 Only patients with COPD on spirometry were included.

290 Cumulative tobacco smoking histories and spirometry were obtained at ages 18, 21, 26, 32, and 38

291 Questionnaire data, HIV status, and standard spirometry were obtained from 1,059, 933, and 749 partic

292 Anthropometry and spirometry were obtained in children aged 6 to 12 years

293 A respiratory questionnaire and standardized spirometry were performed with post-bronchodilator measu

294 PEF and spirometry were recorded in 186 cases and 160 control su

295 03-06, 15,379 never smokers (6497 with valid spirometry) were included in this cross-sectional analys

296 s (including prescreening questionnaires and spirometry); whether screening for COPD improves the del

297 Lung function measurement by means of spirometry with the raised-volume thoracoabdominal compr

298 of exhaled nitric oxide (Feno) maneuvers and spirometry (with forced expiratory time >/=0.5 seconds)

299 ned by the presence of airflow limitation on spirometry, yet subjects with COPD can have marked diffe

300 Spirometry z-scores were derived using the GLI-2012 pred